1. Home
  2. ANIK vs FLC Comparison

ANIK vs FLC Comparison

Compare ANIK & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIK
  • FLC
  • Stock Information
  • Founded
  • ANIK 1983
  • FLC 2003
  • Country
  • ANIK United States
  • FLC United States
  • Employees
  • ANIK N/A
  • FLC N/A
  • Industry
  • ANIK Medical/Dental Instruments
  • FLC Trusts Except Educational Religious and Charitable
  • Sector
  • ANIK Health Care
  • FLC Finance
  • Exchange
  • ANIK Nasdaq
  • FLC Nasdaq
  • Market Cap
  • ANIK 196.6M
  • FLC 174.2M
  • IPO Year
  • ANIK 1993
  • FLC N/A
  • Fundamental
  • Price
  • ANIK $11.23
  • FLC $17.17
  • Analyst Decision
  • ANIK Buy
  • FLC
  • Analyst Count
  • ANIK 1
  • FLC 0
  • Target Price
  • ANIK $19.00
  • FLC N/A
  • AVG Volume (30 Days)
  • ANIK 116.2K
  • FLC 37.8K
  • Earning Date
  • ANIK 08-07-2025
  • FLC 01-01-0001
  • Dividend Yield
  • ANIK N/A
  • FLC 6.64%
  • EPS Growth
  • ANIK N/A
  • FLC N/A
  • EPS
  • ANIK N/A
  • FLC N/A
  • Revenue
  • ANIK $117,053,000.00
  • FLC N/A
  • Revenue This Year
  • ANIK N/A
  • FLC N/A
  • Revenue Next Year
  • ANIK $9.70
  • FLC N/A
  • P/E Ratio
  • ANIK N/A
  • FLC N/A
  • Revenue Growth
  • ANIK 4.61
  • FLC N/A
  • 52 Week Low
  • ANIK $10.47
  • FLC $12.62
  • 52 Week High
  • ANIK $29.12
  • FLC $15.45
  • Technical
  • Relative Strength Index (RSI)
  • ANIK 50.73
  • FLC 68.17
  • Support Level
  • ANIK $10.91
  • FLC $16.86
  • Resistance Level
  • ANIK $11.47
  • FLC $17.12
  • Average True Range (ATR)
  • ANIK 0.49
  • FLC 0.12
  • MACD
  • ANIK 0.11
  • FLC 0.01
  • Stochastic Oscillator
  • ANIK 83.00
  • FLC 100.00

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.

About FLC Flaherty & Crumrine Total Return Fund Inc

Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.

Share on Social Networks: